Judy Wang
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 25
- HER2/EGFR in Cancer Research 7
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 3
-
- Radiopharmaceutical Chemistry and Applications 10
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Raymond M. Reilly (12 shared papers)Deborah A. Scollard (6 shared papers)Paul Chen (6 shared papers)Ross Cameron (4 shared papers)Katherine A. Vallis (5 shared papers)Ying Tang (2 shared papers)Paul Chen (4 shared papers)Claire Holloway (2 shared papers)
- Journals
- Cancer Research (3 papers)Journal of Clinical Oncology (2 papers)ANZ Journal of Surgery (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Nuclear Medicine and Biology (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Judy Wang
47 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 95
- Radiology, Nuclear Medicine and Imaging 411
- Oncology 437
- Structural Biology 18
- Cancer Research 75
- Biomaterials 58
Countries citing papers authored by Judy Wang
This map shows the geographic impact of Judy Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Wang more than expected).
Fields of papers citing papers by Judy Wang
This network shows the impact of papers produced by Judy Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Wang. The network helps show where Judy Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Judy Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 116 | |
| 2 | 2017 | 102 | |
| 3 | Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. | 2006 | 81 |
| 4 | Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. | 2003 | 61 |
| 5 | Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. | 2006 | 55 |
| 6 | 2005 | 52 | |
| 7 | 2020 | 51 | |
| 8 | 2008 | 50 | |
| 9 | 2022 | 45 | |
| 10 | A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis. | 2005 | 42 |
| 11 | 2018 | 39 | |
| 12 | 2005 | 34 | |
| 13 | 2009 | 33 | |
| 14 | 2015 | 33 | |
| 15 | 2022 | 28 | |
| 16 | A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications. | 2004 | 26 |
| 17 | 2004 | 24 | |
| 18 | 2014 | 17 | |
| 19 | 2017 | 17 | |
| 20 | 2006 | 16 |
About Judy Wang
Judy Wang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 49 papers that have together received 1.0k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (411 citations), Oncology (437 citations), Structural Biology (18 citations), Cancer Research (75 citations) and Biomaterials (58 citations). Judy Wang has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Raymond M. Reilly, Deborah A. Scollard, Paul Chen, Ross Cameron, Katherine A. Vallis, Ying Tang, Paul Chen, Claire Holloway, Harriette J. Kahn and Jeanne S. Mandelblatt. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, ANZ Journal of Surgery, European Journal of Nuclear Medicine and Molecular Imaging and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.